Improving Science & Restoring Trust in Public Health | Dr. Jay Bhattacharya
Huberman Lab
2025/06/09
Improving Science & Restoring Trust in Public Health | Dr. Jay Bhattacharya
Improving Science & Restoring Trust in Public Health | Dr. Jay Bhattacharya

Huberman Lab
2025/06/09
Dr. Jay Bhattacharya, the new Director of the National Institutes of Health (NIH) and former Stanford professor, joins the conversation to address critical issues in biomedical research and public health. The discussion explores how the NIH can better support scientific innovation, improve transparency, and rebuild public trust, especially in the wake of the COVID-19 pandemic. Topics include funding priorities, structural challenges in research, and the need for reform in how science is conducted and communicated.
The conversation delves into the NIH’s role in funding both basic and applied research, emphasizing the importance of long-term scientific discovery over short-term gains. Concerns are raised about the rising age of first-time NIH grantees and the systemic bias toward established researchers, which limits opportunities for young scientists. The discussion also highlights inefficiencies in the grant review process, indirect cost structures, and the replication crisis in science. Dr. Bhattacharya outlines efforts to promote transparency, such as public access to taxpayer-funded research, and addresses the influence of careerism and groupthink in limiting scientific progress. The dialogue extends to the sociopolitical aspects of public health, particularly during the pandemic, where issues like vaccine mandates, public messaging, and loss of trust are examined. The conversation concludes with a call to realign NIH priorities to better serve public health needs and foster a more open, innovative scientific culture.
00:00
00:00
Restoring public trust in science is essential for future progress.
06:56
06:56
Jay emphasizes the NIH's long-standing importance in biomedical research
09:14
09:14
Basic research funded by NIH is not patentable but essential for long-term health advancements
25:01
25:01
Stanford has a 55% indirect cost rate on NIH grants, significantly increasing taxpayer expenditure
33:33
33:33
NIH-funded journal publications will be free to the public starting in July
44:48
44:48
American taxpayers largely fund global basic and late-stage research through NIH and high drug prices.
48:50
48:50
President Trump issued an executive order to equalize global drug prices through trade and re-importation policies.
1:05:44
1:05:44
Across-the-board IDC cuts may harm less wealthy universities
1:18:48
1:18:48
R01 proposals often involve work already completed.
1:27:10
1:27:10
Young scientists are more likely to make discoveries due to brain plasticity, energy, and dopamine.
3:09:47
3:09:47
Public health messaging during the pandemic lacked scientific basis, undermining trust in science.